Long Term Open Label Continuation Study

Study Identifier
DE020
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Rheumatoid Arthritis
  • Study Drug
  • Adalimumab
  • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    The purpose of the study was to assess the long-term safety and clinical efficacy following

    repeated administration of adalimumab in patients with rheumatoid arthritis.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 538
    Birmingham, Alabama, United States, 35205
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 4111
    Birmingham, Alabama, United States, 35294-7201
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 4113
    Mobile, Alabama, United States, 36608
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 408
    Anchorage, Alaska, United States, 99508
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 537
    Tucson, Arizona, United States, 85710
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 66822
    Anaheim, California, United States, 92801
    Status
    Not applicable
    Showing {first} - {last} of {total} Results